-
-
公开(公告)号:JPH07277790A
公开(公告)日:1995-10-24
申请号:JP7184394
申请日:1994-04-11
发明人: SHIGENO KEIKO , KADOMA HIDEKI
摘要: PURPOSE:To obtain dust for a hardened material having a short hardening time, having a pH in a neutral range, maintaining high strength until formation of new bone, comprising tricalcium alpha-phosphate, tetracalcium phosphate and calcium hydrogenphosphate as main components. CONSTITUTION:Tricalcium alpha-phosphate is blended with tetracalcium phosphate and calcium hydrogenphosphate as main components in the ratio of Ca/P of 1.40-1.80 to give the objective dust for a hardened material. The dust can be mixed with an X-ray contrast medium, an antimicrobial agent, etc.
-
-
公开(公告)号:JPH07112023A
公开(公告)日:1995-05-02
申请号:JP26201493
申请日:1993-10-20
申请人: UNIV MATSUMOTO SHIKA
发明人: ITO MITSUO
摘要: PURPOSE:To generate in an early period cells and blood vessels into the osteogenesis material formed obtd. by intimately mixing a chitosansol with a mixture composed of oxide powder and inorg. for the oxide powder and hydroxy apatite, animal bones, etc., for the inorg. powder. CONSTITUTION:This osteogenesis material is useful as a filler and supply material used for root canal filling, bone supply, fixing of pyorrhea teeth, etc., in the field of dentistry or orthopedics and includes the mixture composed of the oxide powder and the inorg. powder and includes the chitosan sol kneaded together with this mixture. The calcium silicate, calcium oxide and magnesium oxide are used as the oxide powder. At least one among hydroxy apatite, animal bones, alpha type tricalcium phosphate, and beta type tricalcium phosphate are used as the inorg. powder. As a result, the time when the osteogenesis material decays within the living body is freely controlled and the cells and blood vessels are generated in the osteogenesis material in the early period.
-
公开(公告)号:JPH07112000A
公开(公告)日:1995-05-02
申请号:JP26143793
申请日:1993-10-20
申请人: NIKON CORP
发明人: MOCHIDA MASAAKI
摘要: PURPOSE:To provide a screw-type implant by using which good implantation can be performed by means of direct implantation even when a bone is hard. CONSTITUTION:In a cylinder-type intraosseous implant consisting of a collar part 1 and a main body part 2 provided with a screw below it, the intraosseous implant has the height h of a thread of 0.2-0.4mm, the pitch P of the thread of 0.8-1.7mm and the angle theta formed by a straight line connecting the top of the thread or the lowermost point of the top side with the lowermost point of the bottom side of the thread and the bottom side of the thread of at least 50 and smaller than 90 deg..
-
公开(公告)号:JPH0748109A
公开(公告)日:1995-02-21
申请号:JP12963594
申请日:1994-05-18
IPC分类号: C01B25/32 , A61F2/00 , A61K6/838 , A61L27/12 , C04B35/447
-
-
公开(公告)号:JPH078547A
公开(公告)日:1995-01-13
申请号:JP15878693
申请日:1993-06-29
发明人: FUTAKI KOJI , NISHIO TAKASHI , SHIGENO KEIKO , ONO ICHIRO , SHINODA NORIMASA , OTAGURO MASAZO
摘要: PURPOSE:To provide a sintered type bone filler excellent in strength, toughness and workability which can gradually release a physiologically active material. CONSTITUTION:A sintered type bone filler containing living body absorbable high polymer is characterized by impregnating a porous calcium phosphate compound sintered body block having a Ca/P ratio of 1.3-1.8, a porosity of 0.1-70%, a specific surface area of 0.1-50m /g and a pore diameter of 1nm-10mum with a living body absorbable high polymer material.
-
公开(公告)号:JPH06335521A
公开(公告)日:1994-12-06
申请号:JP12747093
申请日:1993-05-28
申请人: UBE INDUSTRIES
发明人: SAITO YOSHIHIRO , FUKUDA KIMIO , UNE SHIGEMI
摘要: PURPOSE:To provide the curable compsn. of 4CP and/or alpha-TCP having practicable properties meeting applications as medical materials and dental materials. CONSTITUTION:This compsn. consists of the calcium phosphate powder subjected to surface reforming by a film treatment with a high-polymer compd., the powder essentially consisting of this powder and a hardener. The resulted compsn. has excellent bioaffinity and is excellent in terms of sufficient allowance time for operation and physical properties.
-
-
-
-
-
-
-
-
-